Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant
Clinical trial NCT02058589 · COMPLETED
Trial details
- NCT number
- NCT02058589
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-20
- Primary completion
- 2016-05-11
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.